Skip to Content

Novel 660 300 mg (Trimethobenzamide Hydrochloride 300 mg)

Pill with imprint Novel 660 300 mg is Purple, Capsule-shape and has been identified as Trimethobenzamide Hydrochloride 300 mg. It is supplied by Gavis Pharmaceuticals.

Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Novel 660 300 mg

Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg

Trimethobenzamide Hydrochloride

Imprint
Novel 660 300 mg
Strength
300 mg
Color
Purple
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Anticholinergic antiemetics
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gavis Pharmaceuticals
National Drug Code (NDC)
43386-0660
Inactive Ingredients
lactose monohydrate, magnesium stearate, corn starch, D&C Red No. 28, gelatin, FD&C Blue No. 1, FD&C Red No. 40, titanium dioxide, soya lecithin, water, shellac, ethylene glycol monoethyl ether

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.